4//SEC Filing
Lowery Thomas J. 4
Accession 0000899243-19-002638
CIK 0001492674other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:53 PM ET
Size
14.7 KB
Accession
0000899243-19-002638
Insider Transaction Report
Form 4
Lowery Thomas J.
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2018-11-30+15,000→ 73,226 total - Sale
Common Stock
2019-01-31$3.35/sh−2,166$7,256→ 71,060 total - Sale
Common Stock
2019-02-01$3.47/sh−4,185$14,522→ 66,875 total - Exercise/Conversion
Common Stock
2017-11-30+15,000→ 58,226 total - Exercise/Conversion
Restricted Stock Units
2017-11-30−15,000→ 0 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Restricted Stock Units
2018-11-30−15,000→ 0 total→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]On November 30, 2016 the reporting person was granted 30,000 RSU's that vested in two equal annual installments beginning on November 30, 2017.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001615632
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:53 PM ET
- Size
- 14.7 KB